WHAT IS KNOWN:
Watchman device has emerged as an alternative treatment for the
management of stroke risk in AF patients who cannot tolerate oral
anti-coagulation. Randomized trials have demonstrated non-inferiority of
the Watchman device in terms of both efficacy and safety when compared
to coumadin.